Inventor
MCKINNELL ROBERT MURRAY
US72 patents
⚠️ This page may combine multiple inventors who share the name “MCKINNELL ROBERT MURRAY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
THERAVANCE BIOPHARMA R&D IP LLC
15 patentsUS10308646B2Jun 4, 2019
Pyrimidine compound as JAK kinase inhibitor
THERAVANCE BIOPHARMA R&D IP LLC11 citations92
US11420965B2Aug 23, 2022
Pyrimidine compound as JAK kinase inhibitor
THERAVANCE BIOPHARMA R&D IP LLC3 citations84
US10562894B2Feb 18, 2020
Pyrimidine compound as JAK kinase inhibitor
THERAVANCE BIOPHARMA R&D IP LLC7 citations84
US10233172B2Mar 19, 2019
Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
THERAVANCE BIOPHARMA R&D IP LLC4 citations84
US9975877B2May 22, 2018
Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
THERAVANCE BIOPHARMA R&D IP LLC4 citations84
US10538513B2Jan 21, 2020
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
THERAVANCE BIOPHARMA R&D IP LLC4 citations83
US10392368B2Aug 27, 2019
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
THERAVANCE BIOPHARMA R&D IP LLC5 citations80
US11254655B2Feb 22, 2022
Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
THERAVANCE BIOPHARMA R&D IP LLC1 citations73
US11160810B2Nov 2, 2021
Fused imidazo-piperidine JAK inhibitor compound
THERAVANCE BIOPHARMA R&D IP LLC2 citations73
US10696656B2Jun 30, 2020
Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
THERAVANCE BIOPHARMA R&D IP LLC2 citations73
US10968205B2Apr 6, 2021
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
THERAVANCE BIOPHARMA R&D IP LLC1 citations72
US12172994B2Dec 24, 2024
Pyrimidine compound as JAK kinase inhibitor
THERAVANCE BIOPHARMA R&D IP LLC0 citations62
US11339160B2May 24, 2022
Imidazole and triazole containing bicyclic compounds as JAK inhibitors
THERAVANCE BIOPHARMA R&D IP LLC0 citations59
US10851102B2Dec 1, 2020
Imidazole and triazole containing bicyclic compounds as JAK inhibitors
THERAVANCE BIOPHARMA R&D IP LLC1 citations59
US9365549B2Jun 14, 2016
Hepatitis C virus inhibitors
THERAVANCE BIOPHARMA R&D IP LLC0 citations52
THERAVANCE INC
13 patentsUS7879896B2Feb 1, 2011
Dual-acting imidazole antihypertensive agents
THERAVANCE INC53 citations98
US8013005B2Sep 6, 2011
Dual-acting antihypertensive agents
THERAVANCE INC42 citations96
US8377964B2Feb 19, 2013
Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
THERAVANCE INC10 citations93
US8372984B2Feb 12, 2013
Dual-acting oxazole antihypertensive agents
THERAVANCE INC16 citations93
US7759363B2Jul 20, 2010
Benzimidazole-carboxamide compounds as 5-HT4, receptor agonists
THERAVANCE INC18 citations93
US7989484B2Aug 2, 2011
Dual-acting antihypertensive agents
THERAVANCE INC25 citations92
US7956054B2Jun 7, 2011
Dual-acting pyrazole antihypertensive agents
THERAVANCE INC21 citations92
US7863309B2Jan 4, 2011
Dual-acting antihypertensive agents
THERAVANCE INC27 citations92
US7834041B2Nov 16, 2010
Dual-acting antihypertensive agents
THERAVANCE INC29 citations92
US7662815B2Feb 16, 2010
Diaryl ether β2 adrenergic receptor agonists
THERAVANCE INC15 citations84
US7317023B2Jan 8, 2008
Diaryl ether β2 adrenergic receptor agonists
THERAVANCE INC10 citations84
US8344013B2Jan 1, 2013
Dual-acting imidazole antihypertensive agents
THERAVANCE INC4 citations74
US8349875B2Jan 8, 2013
Dual-acting antihypertensive agents
THERAVANCE INC3 citations73
CHOI SEOK-KI
7 patentsUS8212052B2Jul 3, 2012
Dual-acting benzoimidazole antihypertensive agents
CHOI SEOK-KI23 citations92
US9012485B2Apr 21, 2015
Dual-acting imidazole antihypertensive agents
CHOI SEOK-KI2 citations73
US8080572B2Dec 20, 2011
Dual-acting antihypertensive agents
CHOI SEOK-KI5 citations73
US9273008B2Mar 1, 2016
Dual-acting imidazole antihypertensive agents
CHOI SEOK-KI1 citations62
US8664254B2Mar 4, 2014
Dual-acting imidazole antihypertensive agents
CHOI SEOK-KI1 citations62
US8143298B2Mar 27, 2012
Dual-acting antihypertensive agents
CHOI SEOK-KI1 citations62
US8106082B2Jan 31, 2012
Dual-acting antihypertensive agents
CHOI SEOK-KI3 citations62
ALLEGRETTI PAUL
6 patentsUS8158659B2Apr 17, 2012
Dual-acting imidazole antihypertensive agents
ALLEGRETTI PAUL11 citations92
US8895755B2Nov 25, 2014
Intermediates for preparing dual-acting benzyl triazole antihypertensive agents having angiotensin II type I receptor antagonist activity and neprilysin-inhibition activity
ALLEGRETTI PAUL3 citations73
US8569351B2Oct 29, 2013
Dual-acting benzyl triazole antihypertensive agents having angiotensin II type receptor antagonist activity and neprilysin-inhibition activity
ALLEGRETTI PAUL3 citations73
US8236846B2Aug 7, 2012
Dual-acting antihypertensive agents
ALLEGRETTI PAUL5 citations73
US9150514B2Oct 6, 2015
Dual-acting antihypertensive agents
ALLEGRETTI PAUL1 citations62
US8227497B2Jul 24, 2012
Dual-acting antihypertensive agents
ALLEGRETTI PAUL2 citations62
MCKINNELL ROBERT MURRAY
3 patentsUS8143279B2Mar 27, 2012
Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
MCKINNELL ROBERT MURRAY9 citations91
US9428489B2Aug 30, 2016
Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
MCKINNELL ROBERT MURRAY6 citations83
US8921372B2Dec 30, 2014
Inhibitors of hepatitis C virus
MCKINNELL ROBERT MURRAY8 citations82
FATHEREE PAUL R
3 patentsUS8481549B2Jul 9, 2013
Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents
FATHEREE PAUL R5 citations84
US9216970B2Dec 22, 2015
Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents
FATHEREE PAUL R0 citations52
US9181206B2Nov 10, 2015
Dual-acting oxazole antihypertensive agents
FATHEREE PAUL R0 citations52
THERAVANCE BIOPHARMA R & D IP LLC
1 patentBLAIR BROOKE
1 patentHOFFMANN LA ROCHE
1 patentShowing the top 50 of 72 patents by PatentIndex Score.